Pharma Capital

New e-Therapeutics boss 'excited about the future and the steps ahead'

Dr Raymond Barlow talks to Proactive about his new role as CEO of e-Therapeutics PLC (LON:ETX).

He takes over the day to day running of the company from Iain Ross, who is currently executive chairman and fills the role vacated by Professor Malcolm Young, who stepped down last summer.

 

View full ETX profile

e-Therapeutics plc Timeline

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.